MEDTECHS DEFLATE FURTHER
13/03/25 -"It has been some time since AlphaValue last bashed MedTechs, its recurring bête noire when it comes to lofty valuations. In fairness the sector has taken care of itself of late. Five years after ..."
Pages
72
Language
English
Published on
13/03/25
You may also be interested by these reports :
05/10/26
When we last teased on Fresenius (BUY; Germany) in May 2025, the story was about slimming down: shedding Vamed, deconsolidating FMC and working the ...
03/10/26
In addition to our upward revision of estimates (as discussed in the EPS section), the strong momentum in the hearing aids sector, the rebound in ...
28/09/26
Along with the downgrades to our DCF and NAV, we now apply a 10% discount to our peer-based valuation metrics. This reflects S&N’s growth lagging ...
14/09/26
Equity markets ended lower on the week ending September 11 as the renewed surge in energy prices revived inflation concerns and pushed bond yields ...